(0)サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1709486

患者エンゲージメントソリューションの世界市場：コンポーネント別・治療領域別・提供方式別・用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)

Patient Engagement Solutions Market, By Component, By Therapeutic Area, By Delivery Mode, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 269 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.91円
患者エンゲージメントソリューションの世界市場：コンポーネント別・治療領域別・提供方式別・用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)
出版日: 2025年04月04日
発行: AnalystView Market Insights
ページ情報: 英文 269 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

患者エンゲージメントソリューション市場規模は2024年に276億5,043万米ドルとなり、2025年から2032年にかけてCAGR 21.10%で拡大

患者エンゲージメントソリューションの市場力学

遠隔医療導入とデジタル統合の増加により、患者エンゲージメントソリューションが変革

遠隔医療導入とデジタル統合の増加により、患者エンゲージメントソリューションは変化しつつあります。米国医師会（AMA）は、米国の医療提供者の60%以上がバーチャルケアプラットフォームを利用していると報告しています。世界保健機関（WHO）は、患者のアドヒアランス向上におけるデジタルヘルスの役割を強調しており、モバイルヘルスアプリが慢性疾患管理の成功率を40%増加させたことを示しています。米国のHITECH（Health IT for Economic and Clinical Health）法などの政府のイニシアチブは、安全な電子カルテ（EHR）とHIPAA準拠の患者ポータルを推進し、アクセシビリティを高めています。一方、AIを搭載したチャットボットやウェアラブル健康機器は、リアルタイムでの患者モニタリングを再構築し、予測分析を活用して病院の再入院を減らしています。クラウドベースのプラットフォームが医療のワークフローを合理化する中、業界各社はAI主導のソリューションに投資してエンゲージメントをさらに強化し、デジタルトランスフォーメーションが患者中心のケアを世界的に再構築し続けることを確実にしています。

患者エンゲージメントソリューション市場：主な考察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2025-2032年）に約21.10％のCAGRで毎年成長すると推定されます。

コンポーネント別では、ソフトウェアが2024年に最大の市場シェアを示すと予測されています。

治療分野別では、2024年には慢性疾患が主要治療分野となります。

提供方式別では、クラウドベースが2024年の主要デリバリーモードでした。

地域別では、北米が2024年の売上高でトップ

患者エンゲージメントソリューション市場：セグメンテーション分析

世界の患者エンゲージメントソリューション市場は、コンポーネント、治療領域、提供方式、用途、地域に基づいてセグメント化されます。

市場はコンポーネントに基づいて3つのカテゴリーに分けられます：ソフトウェア、サービス、ハードウェアです。ソフトウェアは、EHRプラットフォーム、患者ポータル、AI主導のエンゲージメントツールの採用が増加しているため、市場をリードしています。サービスは、実装、トレーニング、サポートに対する需要の増加により、その後に続きます。ハードウェアのシェアは小さく、主にキオスク端末とウェアラブル医療機器で構成されています。

市場は、治療領域に基づいて2つのカテゴリーに分けられます：慢性疾患、フィットネス、ウィメンズヘルス、メンタルヘルスです。慢性疾患は、患者エンゲージメントソリューションが糖尿病や心血管疾患などの疾患管理を強化することから、市場を独占しています。メンタルヘルスがこれに続き、遠隔治療の採用が増加しています。ウィメンズヘルスとフィットネスは、モバイルヘルスアプリとウェアラブルデバイスの恩恵を受け、シェアは小さいです。

患者エンゲージメントソリューション市場：地域別分析

患者エンゲージメントソリューション市場は世界的に拡大しており、北米は強力な医療インフラ、高い遠隔医療導入率、デジタルヘルスソリューションを促進するHITECH法のような政府の取り組みによりリードしています。米国メディケア＆メディケイドサービスセンター（CMS）は、患者エンゲージメントツールにインセンティブを与え、EHR統合の普及を促進しています。欧州は、一般データ保護規則（GDPR）のような規制政策に支えられ、安全なデジタル患者交流を確保しながら、これに追随しています。アジア太平洋地域は急速な成長を遂げており、中国、日本、インドなどの国々では、医療へのアクセシビリティを高めるため、遠隔医療やモバイルヘルスアプリケーションへの投資が増加しています。ラテンアメリカでは、インターネットの普及拡大や政府主導のデジタルヘルスイニシアチブが市場の成長を促進しており、中東・アフリカでは、スマート医療プロジェクトや世界テック企業との提携を通じて、患者エンゲージメントプラットフォームの導入が徐々に進んでいます。デジタルヘルスの導入が進むにつれ、インフラや規制の地域格差が引き続き市場拡大を形成しています。

患者エンゲージメントソリューション市場：競合情勢

患者エンゲージメント・ソリューション市場は競争が激しく、主要企業は患者との対話を強化するため、AI主導のプラットフォーム、遠隔医療統合、安全なデータ管理に注力しています。Epic Systems、Cerner（Oracle Health）、Allscriptsなどの主要企業は、広範なEHR統合とクラウドベースのソリューションを通じて市場を独占しています。フィリップス、メドトロニック、GEヘルスケアは、ウェアラブル・ヘルス技術とAIを活用したアナリティクスに投資し、遠隔患者モニタリングに取り組んでいます。マイチャート（MyChart）やウェルトック（Welltok）といった新興プレーヤーは、個別化医療に合わせたモバイルベースのエンゲージメント・ツールを提供することで人気を集めています。マイクロソフトとニュアンスのAIを活用した臨床文書作成の提携のような戦略的提携は、業界の形をさらに変えつつあります。規制コンプライアンス、特にHIPAA、GDPR、HL7標準は依然として重要な焦点であり、患者データの安全な取り扱いを保証しています。バーチャルケアへの需要が高まる中、企業はスケーラビリティ、相互運用性、リアルタイムの患者エンゲージメントを優先し、急速に進化するこの市場での競争を激化させています。

目次

第1章 患者エンゲージメントソリューション市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 患者エンゲージメントソリューションの主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 患者エンゲージメントソリューション市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 患者エンゲージメントソリューション市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 患者エンゲージメントソリューションの市場情勢

  • 患者エンゲージメントソリューションの市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 患者エンゲージメントソリューション市場：コンポーネント別

  • 概要
    • セグメント別シェア分析：コンポーネント別
    • ソフトウェア
    • サービス
    • ハードウェア

第8章 患者エンゲージメントソリューション市場：治療領域別

  • 概要
    • セグメント別シェア分析：治療領域別
    • 慢性疾患
    • フィットネス
    • ウィメンズヘルス
    • メンタルヘルス
    • その他

第9章 患者エンゲージメントソリューション市場：提供方式別

  • 概要
    • セグメント別シェア分析：提供方式別
    • オンプレミス
    • クラウドベース

第10章 患者エンゲージメントソリューション市場：用途別

  • 概要
    • セグメント別シェア分析：用途別
    • 健康管理
    • 在宅健康管理
    • 社会行動マネジメント
    • 財務健全性管理

第11章 患者エンゲージメントソリューション市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • スウェーデン
    • ロシア
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • インドネシア
    • タイ
    • フィリピン
    • その他
  • ラテンアメリカ（LATAM）
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ（MEA）
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析：患者エンゲージメントソリューション業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • Allscripts Healthcare Solutions, Inc.
    • Athenahealth, Inc.
    • Cerner Corporation
    • CureMD Healthcare
    • eClinicalWorks
    • Epic Systems Corporation
    • Get Real Health
    • GetWellNetwork, Inc.
    • IBM Corporation
    • Lincor Solutions Ltd.
    • McKesson Corporation
    • Medecision, Inc.
    • Oneview Healthcare PLC
    • Orion Health Ltd.
    • WelVU
    • YourCareUniverse, Inc.
    • Others

第13章 AnalystViewの全方位的分析

目次
Product Code: ANV4959

REPORT HIGHLIGHT

Patient Engagement Solutions Market size was valued at US$ 27,650.43 Million in 2024, expanding at a CAGR of 21.10% from 2025 to 2032.

The Patient Engagement Solutions Market focuses on digital tools and platforms that enhance patient-provider interactions, improve healthcare outcomes, and streamline communication. Increasing adoption of telehealth, with over 40% of U.S. adults using virtual care services, has accelerated demand for these solutions. Government initiatives, such as the CMS Interoperability and Patient Access Rule, are pushing healthcare providers toward integrated engagement platforms. However, data security concerns and interoperability challenges hinder seamless implementation. High initial investment costs also pose barriers for smaller healthcare facilities. Despite these challenges, advancements in AI-driven chatbots and mobile health apps, along with the integration of wearable devices-used by over 30% of global consumers for health monitoring-are creating significant market opportunities. Strategic collaborations between tech companies and healthcare providers are further driving innovation, making patient-centric healthcare more accessible and efficient.

Patient Engagement Solutions Market- Market Dynamics

Rising telehealth adoption and digital integration, transforming patient engagement solutions

Rising telehealth adoption and digital integration are transforming patient engagement solutions, with the American Medical Association (AMA) reporting that over 60% of U.S. healthcare providers now use virtual care platforms. The World Health Organization (WHO) has emphasized digital health's role in improving patient adherence, as mobile health apps have shown a 40% increase in chronic disease management success. Government initiatives, such as the U.S. Health IT for Economic and Clinical Health (HITECH) Act, is promoting secure electronic health records (EHRs) and HIPAA-compliant patient portals to enhance accessibility. Meanwhile, AI-powered chatbots and wearable health devices are reshaping real-time patient monitoring, reducing hospital readmissions by leveraging predictive analytics. As cloud-based platforms streamline healthcare workflows, industry players are investing in AI-driven solutions to further enhance engagement, ensuring that digital transformation continues to reshape patient-centered care globally.

Patient Engagement Solutions Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 21.10% over the forecast period (2025-2032)

Based on Component segmentation, Software was predicted to show maximum market share in the year 2024

Based on Therapeutic Area segmentation, Chronic Diseases was the leading Therapeutic Area in 2024

Based on Delivery Mode segmentation, Cloud-Based was the leading Delivery Mode in 2024

On the basis of region, North America was the leading revenue generator in 2024

Patient Engagement Solutions Market- Segmentation Analysis:

The Global Patient Engagement Solutions Market is segmented on the basis of Component, Therapeutic Area, Delivery Mode, Application, and Region.

The market is divided into three categories based on Component: Software, Services, and Hardware. Software leads the market due to the rising adoption of EHR platforms, patient portals, and AI-driven engagement tools. Services follow, driven by increasing demand for implementation, training, and support. Hardware holds a smaller share, mainly comprising kiosks and wearable health devices.

The market is divided into two categories based on Therapeutic Area: Chronic Diseases, Fitness, Women's Health, and Mental Health. Chronic Diseases dominate the market as patient engagement solutions enhance management of conditions like diabetes and cardiovascular diseases. Mental Health follows, driven by increasing teletherapy adoption. Women's Health and Fitness hold smaller shares, benefiting from mobile health apps and wearable devices.

Patient Engagement Solutions Market- Geographical Insights

The Patient Engagement Solutions Market is expanding globally, with North America leading due to strong healthcare infrastructure, high telehealth adoption, and government initiatives like the HITECH Act promoting digital health solutions. The U.S. Centers for Medicare & Medicaid Services (CMS) has incentivized patient engagement tools, driving widespread EHR integration. Europe follows closely, supported by regulatory policies such as the General Data Protection Regulation (GDPR), ensuring secure digital patient interactions. The Asia-Pacific region is experiencing rapid growth, with countries like China, Japan, and India increasing investments in telemedicine and mobile health applications to enhance healthcare accessibility. In Latin America, expanding internet penetration and government-led digital health initiatives are fostering market growth, while the Middle East & Africa are gradually adopting patient engagement platforms through smart healthcare projects and collaborations with global tech firms. As digital health adoption rises, regional disparities in infrastructure and regulations continue to shape market expansion.

Patient Engagement Solutions Market- Competitive Landscape:

The Patient Engagement Solutions Market is highly competitive, with key players focusing on AI-driven platforms, telehealth integration, and secure data management to enhance patient interactions. Leading companies like Epic Systems, Cerner (Oracle Health), and Allscripts dominate the market through extensive EHR integration and cloud-based solutions. Philips, Medtronic, and GE Healthcare are investing in wearable health technologies and AI-powered analytics for remote patient monitoring. Emerging players, such as MyChart and Welltok, are gaining traction by offering mobile-based engagement tools tailored for personalized healthcare. Strategic collaborations, such as Microsoft's partnership with Nuance for AI-driven clinical documentation, are further reshaping the industry. Regulatory compliance, particularly HIPAA, GDPR, and HL7 standards, remains a key focus, ensuring secure patient data handling. With increasing demand for virtual care, companies are prioritizing scalability, interoperability, and real-time patient engagement, intensifying competition in this rapidly evolving market.

Recent Developments:

In February 2025, Smart Meter unveils SmartHealth Solutions at HIMSS 2025, a suite of AI-powered tools designed to elevate patient engagement. The solutions include a chronic care management app, gait analysis for RTM, AI-enhanced blood pressure coaching, Afib monitoring, and an AI avatar for patient-provider interactions, all aimed at improving health outcomes.

In September 2024, PatientPoint launched PatientPoint Focus(TM) (now Precision(TM)), a solution enabling 1:1 patient engagement before, after, and between visits. Using trusted communication channels and consented EHR data, it delivers relevant educational content to patients, empowering them to have more effective conversations with their doctors and take better actions toward their health.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Allscripts Healthcare Solutions, Inc.
  • Athenahealth, Inc.
  • Cerner Corporation
  • CureMD Healthcare
  • eClinicalWorks
  • Epic Systems Corporation
  • Get Real Health
  • GetWellNetwork, Inc.
  • IBM Corporation
  • Lincor Solutions Ltd.
  • McKesson Corporation
  • Medecision, Inc.
  • Oneview Healthcare PLC
  • Orion Health Ltd.
  • WelVU
  • YourCareUniverse, Inc.
  • Others

GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

  • Software
  • Services
  • Hardware

GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2019 - 2032

  • Chronic Diseases
  • Fitness
  • Women's Health
  • Mental Health
  • Others

GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE- MARKET ANALYSIS, 2019 - 2032

  • On-Premise
  • Cloud-Based

GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Health Management
  • Home Health Management
  • Social and Behavioral Management
  • Financial Health Management

GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Patient Engagement Solutions Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Patient Engagement Solutions Market Snippet by Component
    • 2.1.2. Patient Engagement Solutions Market Snippet by Therapeutic Area
    • 2.1.3. Patient Engagement Solutions Market Snippet by Delivery Mode
    • 2.1.4. Patient Engagement Solutions Market Snippet by Application
    • 2.1.5. Patient Engagement Solutions Market Snippet by Country
    • 2.1.6. Patient Engagement Solutions Market Snippet by Region
  • 2.2. Competitive Insights

3. Patient Engagement Solutions Key Market Trends

  • 3.1. Patient Engagement Solutions Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Patient Engagement Solutions Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Patient Engagement Solutions Market Opportunities
  • 3.4. Patient Engagement Solutions Market Future Trends

4. Patient Engagement Solutions Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Patient Engagement Solutions Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Patient Engagement Solutions Market Landscape

  • 6.1. Patient Engagement Solutions Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Patient Engagement Solutions Market - By Component

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component, 2024 & 2032 (%)
    • 7.1.2. Software
    • 7.1.3. Services
    • 7.1.4. Hardware

8. Patient Engagement Solutions Market - By Therapeutic Area

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Therapeutic Area, 2024 & 2032 (%)
    • 8.1.2. Chronic Diseases
    • 8.1.3. Fitness
    • 8.1.4. Women's Health
    • 8.1.5. Mental Health
    • 8.1.6. Others

9. Patient Engagement Solutions Market - By Delivery Mode

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Delivery Mode, 2024 & 2032 (%)
    • 9.1.2. On-Premise
    • 9.1.3. Cloud-Based

10. Patient Engagement Solutions Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 10.1.2. Health Management
    • 10.1.3. Home Health Management
    • 10.1.4. Social and Behavioral Management
    • 10.1.5. Financial Health Management

11. Patient Engagement Solutions Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Patient Engagement Solutions Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Patient Engagement Solutions Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Patient Engagement Solutions Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Patient Engagement Solutions Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Patient Engagement Solutions Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Patient Engagement Solutions Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Allscripts Healthcare Solutions, Inc.
    • 12.2.2. Athenahealth, Inc.
    • 12.2.3. Cerner Corporation
    • 12.2.4. CureMD Healthcare
    • 12.2.5. eClinicalWorks
    • 12.2.6. Epic Systems Corporation
    • 12.2.7. Get Real Health
    • 12.2.8. GetWellNetwork, Inc.
    • 12.2.9. IBM Corporation
    • 12.2.10. Lincor Solutions Ltd.
    • 12.2.11. McKesson Corporation
    • 12.2.12. Medecision, Inc.
    • 12.2.13. Oneview Healthcare PLC
    • 12.2.14. Orion Health Ltd.
    • 12.2.15. WelVU
    • 12.2.16. YourCareUniverse, Inc.
    • 12.2.17. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us